The Parkinson’s Disease Care New York program, launched by neurologists at UR Medicine, will serve as a national model and provide free care to as many as 500 underserved patients across New York.
Largely unreported in 2006 was the remarkable story of three Rochester virologists whose innovation, dedication, and perseverance resulted in the key breakthrough that lies at the heart of the first vaccine targeting the leading cause of cervical cancer.
The Watchman device was approved by the FDA in 2015, and Strong Memorial Hospital is the first in the Finger Lakes region to offer patients this new minimally invasive therapy.
Medical Center researchers have successfully reduced the symptoms and slowed the progression of Huntington’s disease by replacing sick mouse glia cells with healthy human cells. The findings could ultimately point to a new method to treat the disease.
Wilmot Cancer Institute discovered something simple and inexpensive to reduce pain and tingling in hands and feet due to chemotherapy—exercise.
Neurology professor Gretchen Birbeck has provided care for more than 3,000 patients with seizure disorders in Africa during two decades of work there.
Until now, it was thought the cracks on icy moons such as Pluto’s Charon were the result of processes like plate tectonics. But new computer models suggest that the pull exerted by another object might have been the cause.
David Dean has received an NIH grant explore a novel method of gene therapy delivery that could greatly benefit patients with acute respiratory distress syndrome, a condition that affects about 150,000 people each year.